- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00275769
CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
Study Overview
Detailed Description
The purpose(s) of the study is (are) to evaluate several features available in EnPulse Series pacemaker and report the long term benefit of Atrial Capture Management (ACM) and Ventricular Capture Management (VCM) as demonstrated by accuracy in comparison with manual measurements and variability of ACM and VCM thresholds.
In addition, an evaluation of the timesaving and qualitative benefits of the device feature known as Quick Look II (the computer interface screen of the device programmer) will be measured through the use of a questionnaire completed by the health care professionals involved in patient follow-up care.
This is a one-to-one randomized, multicenter, prospective study in which patients receiving new EnPulse pacemaker implants will be randomized to each of three study arms, 1) routine manual follow-up and follow-up using the automatic features; 2) ACM diagnostics detail on or VCM diagnostics detail on; 3) PMOP on / off or PMOP off / on (6 month cycle).
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Quebec, Canada
-
-
British Columbia
-
North Vancouver, British Columbia, Canada
-
-
Ontario
-
Kitchener, Ontario, Canada
-
Toronto, Ontario, Canada
-
-
Quebec
-
Laval, Quebec, Canada
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada
-
-
-
-
Alabama
-
Anchorage, Alabama, United States
-
Mobil, Alabama, United States
-
-
California
-
Fullerton, California, United States
-
Oceanside, California, United States
-
Redondo Beach, California, United States
-
Stanford, California, United States
-
-
Colorado
-
Colorado Springs, Colorado, United States
-
-
District of Columbia
-
Washington, District of Columbia, United States
-
-
Florida
-
Brandon, Florida, United States
-
Daytona Beach, Florida, United States
-
Orlando, Florida, United States
-
Sarasota, Florida, United States
-
-
Georgia
-
Athens, Georgia, United States
-
Gainsville, Georgia, United States
-
-
Illinois
-
Chicago, Illinois, United States
-
Peoria, Illinois, United States
-
-
Iowa
-
Des Moines, Iowa, United States
-
-
Kansas
-
Kansas City, Kansas, United States
-
-
Maine
-
Worcester, Maine, United States
-
-
Massachusetts
-
Burlington, Massachusetts, United States
-
-
Michigan
-
Petoskey, Michigan, United States
-
-
Minnesota
-
St. Paul, Minnesota, United States
-
-
Mississippi
-
Jackson, Mississippi, United States
-
-
Missouri
-
Columbia, Missouri, United States
-
St. Louis, Missouri, United States
-
-
New Jersey
-
Flemington, New Jersey, United States
-
Newark, New Jersey, United States
-
Paramus, New Jersey, United States
-
-
New Mexico
-
Albuquerque, New Mexico, United States
-
-
New York
-
Fayetteville, New York, United States
-
New York, New York, United States
-
-
North Carolina
-
High Point, North Carolina, United States
-
-
Ohio
-
Akron, Ohio, United States
-
Cleveland, Ohio, United States
-
Steubenville, Ohio, United States
-
-
Oklahoma
-
Lawton, Oklahoma, United States
-
-
Oregon
-
Tualatin, Oregon, United States
-
-
Pennsylvania
-
Altoona, Pennsylvania, United States
-
Philadelphia, Pennsylvania, United States
-
-
Rhode Island
-
Pawtucket, Rhode Island, United States
-
-
South Carolina
-
Columbia, South Carolina, United States
-
Greenville, South Carolina, United States
-
-
South Dakota
-
Sioux Falls, South Dakota, United States
-
-
Tennessee
-
Knoxville, Tennessee, United States
-
Oak Ridge, Tennessee, United States
-
-
Texas
-
Forth Worth, Texas, United States
-
Houston, Texas, United States
-
-
Virginia
-
Richmond, Virginia, United States
-
-
Washington
-
Spokane, Washington, United States
-
-
West Virginia
-
Charleston, West Virginia, United States
-
-
Wisconsin
-
Wausau, Wisconsin, United States
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Patients that meet ACC/AHA/NASPE 2002 class I or II dual chamber pacing indications (intended for a Pacing Mode programmed to DDD or DDDR)
Exclusion Criteria:
- Patient with mechanical tricuspid heart valves
- Patients with medical conditions that preclude the testing required by the protocol or limit study participation
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
The automatic device features Atrial Capture Management and Ventricular Capture Management measure pacing thresholds and is compared to manual pacing thresholds observed at the 6 month follow-up visit
|
Secondary Outcome Measures
Outcome Measure |
---|
Observe the variability of multiple pacing thresholds measured with ACM and VCM
|
Observe visit time differences using automatic measurements versus traditional follow-up
|
Observe the effects of Post Mode Switch Overdrive Pacing (PMOP) on AT/AF burden.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Stephen W. Mester, MD, Tampa General Hospital
- Principal Investigator: Lawrence S. Rosenthal, MD, Umass Memorial Medical Center
- Principal Investigator: Raymond Gendreau, MD, Cite di la Sante de Laval
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 229
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bradycardia
-
Augusta UniversityCompletedFetal BradycardiaUnited States
-
University of Maryland, BaltimoreCompleted
-
Chun Chieh WangEnrolling by invitation
-
University of Sao Paulo General HospitalCompletedFetal Bradycardia | Hypertonic Uterine | CatecholaminesBrazil
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustCompletedSVT | Vagal BradycardiaUnited Kingdom
-
Medical University of GdanskCompletedBradycardia During Pulling of EyeballPoland
-
Abbott Medical DevicesCompletedStandard Bradycardia Pacing IndicationFrance, Germany, Italy, Japan
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
South Western Ambulance Service NHS Foundation...Royal Devon and Exeter NHS Foundation Trust; Academic Health Science CentresCompletedEmergencies | SVT | Vagal BradycardiaUnited Kingdom
-
Unyime ItukRecruitingFetal Heart Rate or Rhythm Abnormality Affecting Fetus | Fetal Bradycardia Complicating Labor and Delivery | Fetal Bradycardia During LaborUnited States
Clinical Trials on Pacemaker
-
Ajou University School of MedicineRecruitingObesity | Arrhythmias, Cardiac | Cardiovascular Morbidity | Pacemaker ComplicationKorea, Republic of
-
Region GävleborgUnknown
-
Abbott Medical DevicesTerminated
-
Imperial College LondonBritish Heart FoundationRecruitingBradycardia | Left Bundle Branch Area Pacing | His Bundle Pacing | Right Ventricular Pacing | PacingUnited Kingdom
-
Arun RaoMedtronicCompletedSinus Node DysfunctionUnited States
-
Massachusetts General HospitalMedtronicRecruiting
-
Manchester University NHS Foundation TrustAbbott Medical Devices; British Heart FoundationCompletedVentricular Dysfunction | Ventricular RemodellingUnited Kingdom
-
University of CalgaryCalgary Health TrustTerminatedAtrial Fibrillation | Cardiac Pacing, ArtificialCanada
-
Biotronik Canada IncCompletedCardiac Pacemaker, ArtificialCanada
-
Hamilton Health Sciences CorporationSunnybrook Health Sciences Centre; MedtronicCompleted